Cardinal Health Inc (CAH) reported quarterly earnings results on Thursday, Apr-28-2016. The company said it had a profit of $1.43 Earnings per Share for the quarter. The results exceeded Wall Street expectations beating the analyst consensus estimate by $0.10. Analysts had a consensus of $1.33. The company posted revenue of $30662.00 million in the period, compared to analysts expectations of $30439.59 million. The company’s revenue was up 20.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.19 EPS.
Many Wall Street Analysts have commented on Cardinal Health Inc. Avondale Initiated Cardinal Health Inc on Apr 19, 2016 to “Mkt Outperform”, Price Target of the shares are set at $111.Cardinal Health Inc was Initiated by Credit Suisse to “Outperform” on Mar 16, 2016. Shares were Reiterated by RBC Capital Mkts on Feb 11, 2016 to “Outperform” and Lowered the Price Target to $ 95 from a previous price target of $105 .
Cardinal Health Inc closed down -0.04 points or -0.05% at $86.54 with 19,07,694 shares getting traded on Wednesday. Post opening the session at $86.89, the shares hit an intraday low of $86.37 and an intraday high of $87.16 and the price fluctuated in this range throughout the day.Shares ended Wednesday session in Red.
In a different news, on Nov 12, 2015, George S Barrett (Chairman and CEO) sold 54,658 shares at $87.73 per share price. According to the SEC, on Nov 9, 2015, Falk T Stephen (EVP, Gen. Counsel & Corp. Sec.) sold 30,085 shares at $87.66 per share price. On Aug 7, 2015, David J Anderson (director) purchased 1,400 shares at $86.41 per share price, according to the Form-4 filing with the securities and exchange commission.
Cardinal Health Inc. is a healthcare services and products company. The Company operates in two segments: Pharmaceutical and Medical. The Company also provides medical products to patients in the home. In the United States the Company’s Pharmaceutical segment distributes branded and generic pharmaceutical over-the-counter healthcare and consumer products through its Pharmaceutical Distribution division to retailers hospitals and other healthcare providers. In China the Pharmaceutical segment distributes branded generic and specialty pharmaceutical over-the-counter healthcare and consumer products provides logistics marketing and other services and operates direct-to-patient specialty pharmacies through Cardinal Health China. The Medical segment distributes a range of medical surgical and laboratory products and provides services to hospitals ambulatory surgery centers clinical laboratories and other healthcare providers.